Genus (LON:GNS) Price Target Raised to GBX 3,300 at Deutsche Bank Aktiengesellschaft

Genus (LON:GNSFree Report) had its price objective boosted by Deutsche Bank Aktiengesellschaft from GBX 3,100 to GBX 3,300 in a research note released on Friday morning,Digital Look reports. The brokerage currently has a buy rating on the stock.

Several other research analysts have also commented on the stock. Shore Capital reaffirmed a “buy” rating and issued a GBX 3,000 price target on shares of Genus in a report on Friday. Berenberg Bank raised their target price on shares of Genus from GBX 3,050 to GBX 3,250 and gave the stock a “buy” rating in a report on Friday. Three analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock has an average rating of “Buy” and an average target price of GBX 3,183.33.

Get Our Latest Report on Genus

Genus Stock Performance

Genus stock remained flat at GBX 2,835 during mid-day trading on Friday. 125,068 shares of the company’s stock were exchanged, compared to its average volume of 305,460. The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.12. Genus has a 1 year low of GBX 1,548 and a 1 year high of GBX 3,228.80. The firm’s fifty day moving average is GBX 2,548.09 and its 200 day moving average is GBX 2,517.50. The company has a market capitalization of £1.88 billion, a price-to-earnings ratio of 98.10, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37.

About Genus

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.

Featured Stories

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.